Obesity Trials in City of Saint Peters, United States
Conditions / Obesity / City of Saint Peters, United States
Obesity is a medical condition with active clinical research programs worldwide.
39 total trials for this combination
Showing top 10 of 39 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05929066 | A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05556512 | A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05872620 | A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT05514535 | A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE) | COMPLETED | PHASE3 |
| NCT05929079 | A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT07037433 | Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity | RECRUITING | PHASE3 |
| NCT05803421 | A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk | COMPLETED | — |
| NCT06066528 | A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05882045 | A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05394519 | A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight | COMPLETED | PHASE3 |